Insider · CIK 0001937147
Funicular Funds, LP
Files at ORKA (ARCA biopharma, Inc.), LITS (MEI Pharma, Inc.). First filing -, latest -.
In brief
Funicular Funds, LP files SEC Form 4 as 10% owner at ORKA (ARCA biopharma, Inc.), and also at LITS (MEI Pharma, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Funicular Funds, LP has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Planned sales
Form 144 notices this insider filed before selling restricted or control stock, newest first.
| Filed | Company | Shares | Value | Sale date | Past 3 months |
|---|---|---|---|---|---|
| Jul 23, 2025 | LITS MEI Pharma, Inc. | 611,440 2.05% of outstanding | $3.8M | Jul 23, 2025 | none |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Oct 20, 2023 | LITS MEI Pharma, Inc. | XIn-the-money exercise Common Stockindirect: By Funicular Funds, LP | +120,600 | $7.00 | $844k | 611,440 | Oct 24, 2023 |
| Oct 20, 2023 | LITS MEI Pharma, Inc. | XIn-the-money exercise Put Option (obligation to buy)derivativeindirect: By Funicular Funds, LP | -1,206 | $0.00 | $0 | 4,494 | Oct 24, 2023 |
| Oct 20, 2023 | LITS MEI Pharma, Inc. | EExpiration of short derivative Put Option (obligation to buy)derivativeindirect: By Funicular Funds, LP | -4,494 | $0.00 | $0 | 0 | Oct 24, 2023 |
| Oct 11, 2023 | LITS MEI Pharma, Inc. | XIn-the-money exercise Common Stockindirect: By Funicular Funds, LP | +30,000 | $7.00 | $210k | 490,840 | Oct 13, 2023 |
| Oct 11, 2023 | LITS MEI Pharma, Inc. | XIn-the-money exercise Put Option (obligation to buy)derivativeindirect: By Funicular Funds, LP | -300 | $0.00 | $0 | 5,700 | Oct 13, 2023 |
Questions about Funicular Funds, LP
Answered from the filings on this page, as of the latest one.
Is Funicular Funds, LP buying or selling?
Funicular Funds, LP has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Funicular Funds, LP's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Funicular Funds, LP has 0.
Where does Funicular Funds, LP file Form 4?
Funicular Funds, LP has filed Form 4 at ORKA (ARCA biopharma, Inc.); LITS (MEI Pharma, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.